Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
NEUROGENESIS |
355 |
1402 |
2.564e-20 |
1.193e-16 |
2 |
RESPONSE TO ENDOGENOUS STIMULUS |
348 |
1450 |
4.232e-16 |
5.867e-13 |
3 |
PROTEIN LOCALIZATION |
416 |
1805 |
5.043e-16 |
5.867e-13 |
4 |
REGULATION OF TRANSPORT |
417 |
1804 |
2.764e-16 |
5.867e-13 |
5 |
CELL DEVELOPMENT |
339 |
1426 |
4.462e-15 |
4.153e-12 |
6 |
POSITIVE REGULATION OF GENE EXPRESSION |
396 |
1733 |
1.161e-14 |
9.002e-12 |
7 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
380 |
1656 |
2.282e-14 |
1.18e-11 |
8 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
209 |
788 |
2.029e-14 |
1.18e-11 |
9 |
CIRCULATORY SYSTEM DEVELOPMENT |
209 |
788 |
2.029e-14 |
1.18e-11 |
10 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
382 |
1672 |
3.796e-14 |
1.766e-11 |
11 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
437 |
1977 |
1.108e-13 |
4.383e-11 |
12 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
251 |
1008 |
1.13e-13 |
4.383e-11 |
13 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
402 |
1791 |
1.227e-13 |
4.39e-11 |
14 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
239 |
957 |
3.272e-13 |
1.015e-10 |
15 |
POSITIVE REGULATION OF CELL COMMUNICATION |
351 |
1532 |
3.229e-13 |
1.015e-10 |
16 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
402 |
1805 |
4.094e-13 |
1.191e-10 |
17 |
REGULATION OF CELLULAR LOCALIZATION |
301 |
1277 |
5.526e-13 |
1.512e-10 |
18 |
VASCULATURE DEVELOPMENT |
136 |
469 |
9.142e-13 |
2.363e-10 |
19 |
CELL PROJECTION ORGANIZATION |
225 |
902 |
1.91e-12 |
4.678e-10 |
20 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
274 |
1152 |
2.313e-12 |
5.381e-10 |
21 |
REGULATION OF PROTEIN LOCALIZATION |
234 |
950 |
2.673e-12 |
5.654e-10 |
22 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
198 |
771 |
2.658e-12 |
5.654e-10 |
23 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
181 |
689 |
2.989e-12 |
5.863e-10 |
24 |
POSITIVE REGULATION OF TRANSPORT |
231 |
936 |
3.024e-12 |
5.863e-10 |
25 |
RESPONSE TO HORMONE |
222 |
893 |
3.861e-12 |
7.049e-10 |
26 |
PROTEIN PHOSPHORYLATION |
232 |
944 |
4.242e-12 |
7.049e-10 |
27 |
TISSUE DEVELOPMENT |
343 |
1518 |
4.138e-12 |
7.049e-10 |
28 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
393 |
1784 |
3.942e-12 |
7.049e-10 |
29 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
323 |
1423 |
1.064e-11 |
1.65e-09 |
30 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
341 |
1518 |
1.045e-11 |
1.65e-09 |
31 |
INTRACELLULAR SIGNAL TRANSDUCTION |
351 |
1572 |
1.124e-11 |
1.687e-09 |
32 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
191 |
750 |
1.446e-11 |
2.102e-09 |
33 |
REGULATION OF CELL PROJECTION ORGANIZATION |
151 |
558 |
1.864e-11 |
2.628e-09 |
34 |
REGULATION OF NEURON DIFFERENTIATION |
150 |
554 |
2.081e-11 |
2.848e-09 |
35 |
NEURON DIFFERENTIATION |
215 |
874 |
2.463e-11 |
3.274e-09 |
36 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
149 |
552 |
3.109e-11 |
4.018e-09 |
37 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
243 |
1021 |
4.146e-11 |
5.213e-09 |
38 |
CELLULAR COMPONENT MORPHOGENESIS |
219 |
900 |
4.715e-11 |
5.774e-09 |
39 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
314 |
1395 |
5.948e-11 |
7.096e-09 |
40 |
REGULATION OF CELL DIFFERENTIATION |
332 |
1492 |
6.702e-11 |
7.796e-09 |
41 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
265 |
1142 |
8.652e-11 |
9.819e-09 |
42 |
REGULATION OF CELL DEVELOPMENT |
205 |
836 |
9.858e-11 |
1.092e-08 |
43 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
273 |
1192 |
1.87e-10 |
2.024e-08 |
44 |
BLOOD VESSEL MORPHOGENESIS |
106 |
364 |
2.284e-10 |
2.415e-08 |
45 |
PHOSPHORYLATION |
279 |
1228 |
2.81e-10 |
2.906e-08 |
46 |
CELLULAR RESPONSE TO STRESS |
342 |
1565 |
3.237e-10 |
3.274e-08 |
47 |
NEURON DEVELOPMENT |
173 |
687 |
3.481e-10 |
3.447e-08 |
48 |
UROGENITAL SYSTEM DEVELOPMENT |
91 |
299 |
3.568e-10 |
3.459e-08 |
49 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
134 |
498 |
3.868e-10 |
3.673e-08 |
50 |
NEURON PROJECTION DEVELOPMENT |
143 |
545 |
6.535e-10 |
6.081e-08 |
51 |
REGULATION OF GTPASE ACTIVITY |
169 |
673 |
7.012e-10 |
6.398e-08 |
52 |
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
208 |
873 |
1.022e-09 |
9.145e-08 |
53 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
214 |
905 |
1.161e-09 |
1.019e-07 |
54 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
233 |
1004 |
1.267e-09 |
1.092e-07 |
55 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
90 |
303 |
1.745e-09 |
1.476e-07 |
56 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
364 |
1710 |
2.222e-09 |
1.846e-07 |
57 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
84 |
278 |
2.464e-09 |
2.011e-07 |
58 |
HEAD DEVELOPMENT |
174 |
709 |
2.514e-09 |
2.017e-07 |
59 |
CELLULAR MACROMOLECULE LOCALIZATION |
275 |
1234 |
2.91e-09 |
2.295e-07 |
60 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
112 |
408 |
3.159e-09 |
2.45e-07 |
61 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
118 |
437 |
3.454e-09 |
2.634e-07 |
62 |
CELL PART MORPHOGENESIS |
158 |
633 |
3.98e-09 |
2.987e-07 |
63 |
VESICLE MEDIATED TRANSPORT |
275 |
1239 |
4.4e-09 |
3.249e-07 |
64 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
387 |
1848 |
5.062e-09 |
3.68e-07 |
65 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
184 |
767 |
5.62e-09 |
4.023e-07 |
66 |
HEART DEVELOPMENT |
123 |
466 |
7.043e-09 |
4.965e-07 |
67 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
280 |
1275 |
9.314e-09 |
6.469e-07 |
68 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
72 |
232 |
9.709e-09 |
6.644e-07 |
69 |
NEURON PROJECTION MORPHOGENESIS |
109 |
402 |
1.065e-08 |
7.183e-07 |
70 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
66 |
207 |
1.217e-08 |
8.086e-07 |
71 |
PROTEIN CATABOLIC PROCESS |
145 |
579 |
1.39e-08 |
9.108e-07 |
72 |
PROTEIN UBIQUITINATION |
155 |
629 |
1.411e-08 |
9.12e-07 |
73 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
88 |
306 |
1.457e-08 |
9.285e-07 |
74 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
123 |
472 |
1.576e-08 |
9.912e-07 |
75 |
ANGIOGENESIS |
85 |
293 |
1.645e-08 |
1.021e-06 |
76 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
139 |
552 |
1.926e-08 |
1.179e-06 |
77 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
173 |
724 |
2.179e-08 |
1.317e-06 |
78 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
341 |
1618 |
2.327e-08 |
1.388e-06 |
79 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
192 |
823 |
2.524e-08 |
1.487e-06 |
80 |
REGULATION OF HYDROLASE ACTIVITY |
287 |
1327 |
2.813e-08 |
1.636e-06 |
81 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
130 |
513 |
3.726e-08 |
2.14e-06 |
82 |
REGULATION OF ORGANELLE ORGANIZATION |
258 |
1178 |
4.759e-08 |
2.701e-06 |
83 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
200 |
872 |
5.075e-08 |
2.845e-06 |
84 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
395 |
1929 |
5.264e-08 |
2.916e-06 |
85 |
RESPONSE TO STEROID HORMONE |
126 |
497 |
5.867e-08 |
3.201e-06 |
86 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
349 |
1676 |
5.915e-08 |
3.201e-06 |
87 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
69 |
229 |
7.18e-08 |
3.84e-06 |
88 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
99 |
368 |
7.552e-08 |
3.993e-06 |
89 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
185 |
799 |
8.064e-08 |
4.216e-06 |
90 |
MUSCLE STRUCTURE DEVELOPMENT |
112 |
432 |
9.169e-08 |
4.741e-06 |
91 |
LOCOMOTION |
244 |
1114 |
1.117e-07 |
5.71e-06 |
92 |
POSITIVE REGULATION OF LOCOMOTION |
109 |
420 |
1.284e-07 |
6.496e-06 |
93 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
289 |
1360 |
1.395e-07 |
6.978e-06 |
94 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
206 |
917 |
1.667e-07 |
8.253e-06 |
95 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
292 |
1381 |
1.923e-07 |
9.418e-06 |
96 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
63 |
208 |
2.122e-07 |
1.028e-05 |
97 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
94 |
352 |
2.307e-07 |
1.106e-05 |
98 |
RESPONSE TO NITROGEN COMPOUND |
194 |
859 |
2.598e-07 |
1.234e-05 |
99 |
REGULATION OF SYNAPTIC PLASTICITY |
47 |
140 |
2.713e-07 |
1.262e-05 |
100 |
REGULATION OF INTRACELLULAR TRANSPORT |
148 |
621 |
2.7e-07 |
1.262e-05 |
101 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
68 |
232 |
2.826e-07 |
1.302e-05 |
102 |
CELLULAR RESPONSE TO PEPTIDE |
77 |
274 |
3.182e-07 |
1.452e-05 |
103 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
116 |
462 |
3.34e-07 |
1.509e-05 |
104 |
SINGLE ORGANISM BEHAVIOR |
100 |
384 |
3.523e-07 |
1.576e-05 |
105 |
RESPONSE TO WOUNDING |
136 |
563 |
3.678e-07 |
1.63e-05 |
106 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
48 |
146 |
4.126e-07 |
1.803e-05 |
107 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
79 |
285 |
4.145e-07 |
1.803e-05 |
108 |
EMBRYONIC MORPHOGENESIS |
131 |
539 |
4.21e-07 |
1.814e-05 |
109 |
EPITHELIUM DEVELOPMENT |
209 |
945 |
4.535e-07 |
1.936e-05 |
110 |
REGULATION OF MEMBRANE POTENTIAL |
91 |
343 |
4.881e-07 |
2.046e-05 |
111 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
104 |
406 |
4.87e-07 |
2.046e-05 |
112 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
47 |
143 |
5.474e-07 |
2.274e-05 |
113 |
REGULATION OF CELL MORPHOGENESIS |
133 |
552 |
5.74e-07 |
2.364e-05 |
114 |
MUSCLE CELL DIFFERENTIATION |
68 |
237 |
6.702e-07 |
2.736e-05 |
115 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
125 |
514 |
7.445e-07 |
3.012e-05 |
116 |
REGULATION OF SECRETION |
161 |
699 |
7.907e-07 |
3.172e-05 |
117 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
56 |
184 |
8.254e-07 |
3.282e-05 |
118 |
MACROMOLECULE CATABOLIC PROCESS |
204 |
926 |
8.325e-07 |
3.283e-05 |
119 |
REGULATION OF TRANSPORTER ACTIVITY |
59 |
198 |
9.277e-07 |
3.628e-05 |
120 |
REGULATION OF CYTOPLASMIC TRANSPORT |
118 |
481 |
9.476e-07 |
3.674e-05 |
121 |
TUBE DEVELOPMENT |
132 |
552 |
9.765e-07 |
3.755e-05 |
122 |
MODULATION OF SYNAPTIC TRANSMISSION |
81 |
301 |
1.104e-06 |
4.209e-05 |
123 |
RESPONSE TO LIPID |
196 |
888 |
1.199e-06 |
4.536e-05 |
124 |
EPITHELIAL CELL DEVELOPMENT |
56 |
186 |
1.209e-06 |
4.538e-05 |
125 |
EMBRYO DEVELOPMENT |
197 |
894 |
1.265e-06 |
4.71e-05 |
126 |
CELLULAR CATABOLIC PROCESS |
276 |
1322 |
1.293e-06 |
4.73e-05 |
127 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
93 |
360 |
1.301e-06 |
4.73e-05 |
128 |
STRIATED MUSCLE CELL DIFFERENTIATION |
53 |
173 |
1.285e-06 |
4.73e-05 |
129 |
RESPONSE TO ABIOTIC STIMULUS |
221 |
1024 |
1.411e-06 |
5.09e-05 |
130 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
122 |
505 |
1.444e-06 |
5.168e-05 |
131 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
114 |
465 |
1.49e-06 |
5.254e-05 |
132 |
RESPONSE TO GROWTH FACTOR |
116 |
475 |
1.484e-06 |
5.254e-05 |
133 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
129 |
541 |
1.516e-06 |
5.266e-05 |
134 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
129 |
541 |
1.516e-06 |
5.266e-05 |
135 |
REGULATION OF DEVELOPMENTAL GROWTH |
78 |
289 |
1.53e-06 |
5.273e-05 |
136 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
158 |
691 |
1.581e-06 |
5.408e-05 |
137 |
DEVELOPMENTAL GROWTH |
87 |
333 |
1.719e-06 |
5.801e-05 |
138 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
197 |
898 |
1.733e-06 |
5.801e-05 |
139 |
RENAL SYSTEM PROCESS |
36 |
102 |
1.728e-06 |
5.801e-05 |
140 |
TISSUE MORPHOGENESIS |
127 |
533 |
1.898e-06 |
6.308e-05 |
141 |
CATABOLIC PROCESS |
356 |
1773 |
1.918e-06 |
6.329e-05 |
142 |
REGULATION OF GLUCOSE IMPORT |
25 |
60 |
2.118e-06 |
6.94e-05 |
143 |
REGULATION OF METAL ION TRANSPORT |
85 |
325 |
2.149e-06 |
6.994e-05 |
144 |
SECRETION BY CELL |
117 |
486 |
2.821e-06 |
9.114e-05 |
145 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
87 |
337 |
2.904e-06 |
9.31e-05 |
146 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
166 |
740 |
2.921e-06 |
9.31e-05 |
147 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
41 |
125 |
2.992e-06 |
9.47e-05 |
148 |
REGULATION OF CELL CYCLE |
205 |
949 |
3.208e-06 |
0.0001009 |
149 |
APPENDAGE DEVELOPMENT |
51 |
169 |
3.291e-06 |
0.0001021 |
150 |
LIMB DEVELOPMENT |
51 |
169 |
3.291e-06 |
0.0001021 |
151 |
REGULATION OF NEURON APOPTOTIC PROCESS |
56 |
192 |
3.605e-06 |
0.0001111 |
152 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
177 |
801 |
3.673e-06 |
0.0001124 |
153 |
POST EMBRYONIC DEVELOPMENT |
32 |
89 |
4.058e-06 |
0.0001234 |
154 |
REGULATION OF EPITHELIAL CELL MIGRATION |
50 |
166 |
4.338e-06 |
0.0001311 |
155 |
WOUND HEALING |
113 |
470 |
4.424e-06 |
0.0001328 |
156 |
GROWTH |
101 |
410 |
4.633e-06 |
0.0001382 |
157 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
133 |
573 |
4.69e-06 |
0.000139 |
158 |
ACTION POTENTIAL |
33 |
94 |
5.249e-06 |
0.0001546 |
159 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
307 |
1517 |
5.331e-06 |
0.0001558 |
160 |
NEGATIVE REGULATION OF MAPK CASCADE |
45 |
145 |
5.392e-06 |
0.0001558 |
161 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
154 |
684 |
5.361e-06 |
0.0001558 |
162 |
PROTEOLYSIS |
251 |
1208 |
5.779e-06 |
0.000166 |
163 |
COGNITION |
68 |
251 |
6.061e-06 |
0.000173 |
164 |
NEGATIVE REGULATION OF CELL DEATH |
189 |
872 |
6.257e-06 |
0.0001775 |
165 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
34 |
99 |
6.614e-06 |
0.0001854 |
166 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
34 |
99 |
6.614e-06 |
0.0001854 |
167 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
55 |
191 |
6.673e-06 |
0.0001859 |
168 |
NEURON PROJECTION GUIDANCE |
58 |
205 |
6.897e-06 |
0.000191 |
169 |
ERBB SIGNALING PATHWAY |
29 |
79 |
7.081e-06 |
0.0001949 |
170 |
SECRETION |
135 |
588 |
7.205e-06 |
0.0001972 |
171 |
BEHAVIOR |
121 |
516 |
7.466e-06 |
0.0002032 |
172 |
REGULATION OF BODY FLUID LEVELS |
119 |
506 |
7.666e-06 |
0.0002074 |
173 |
MORPHOGENESIS OF AN EPITHELIUM |
98 |
400 |
8.143e-06 |
0.000219 |
174 |
RESPONSE TO OXYGEN LEVELS |
80 |
311 |
8.248e-06 |
0.0002206 |
175 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
19 |
42 |
8.322e-06 |
0.0002213 |
176 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
301 |
1492 |
8.615e-06 |
0.0002265 |
177 |
REGULATION OF CYTOSKELETON ORGANIZATION |
118 |
502 |
8.567e-06 |
0.0002265 |
178 |
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS |
11 |
17 |
8.871e-06 |
0.0002319 |
179 |
INSULIN RECEPTOR SIGNALING PATHWAY |
29 |
80 |
9.411e-06 |
0.0002446 |
180 |
CELLULAR RESPONSE TO LIPID |
109 |
457 |
9.473e-06 |
0.0002449 |
181 |
CELL MOTILITY |
181 |
835 |
9.75e-06 |
0.0002493 |
182 |
LOCALIZATION OF CELL |
181 |
835 |
9.75e-06 |
0.0002493 |
183 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
102 |
422 |
9.983e-06 |
0.0002538 |
184 |
RESPONSE TO OXIDATIVE STRESS |
88 |
352 |
1.009e-05 |
0.0002552 |
185 |
TUBE MORPHOGENESIS |
82 |
323 |
1.088e-05 |
0.0002736 |
186 |
RESPONSE TO INORGANIC SUBSTANCE |
113 |
479 |
1.111e-05 |
0.000278 |
187 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
208 |
983 |
1.13e-05 |
0.0002811 |
188 |
NEGATIVE REGULATION OF GENE EXPRESSION |
300 |
1493 |
1.242e-05 |
0.0003041 |
189 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
60 |
218 |
1.233e-05 |
0.0003041 |
190 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
36 |
110 |
1.238e-05 |
0.0003041 |
191 |
MULTICELLULAR ORGANISMAL SIGNALING |
39 |
123 |
1.273e-05 |
0.0003101 |
192 |
REGULATION OF FAT CELL DIFFERENTIATION |
35 |
106 |
1.307e-05 |
0.0003169 |
193 |
CELL CYCLE |
268 |
1316 |
1.354e-05 |
0.0003264 |
194 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
96 |
395 |
1.421e-05 |
0.0003407 |
195 |
RESPONSE TO INSULIN |
57 |
205 |
1.451e-05 |
0.0003444 |
196 |
NEGATIVE REGULATION OF JNK CASCADE |
16 |
33 |
1.451e-05 |
0.0003444 |
197 |
ORGAN MORPHOGENESIS |
181 |
841 |
1.516e-05 |
0.0003561 |
198 |
RESPONSE TO DRUG |
103 |
431 |
1.51e-05 |
0.0003561 |
199 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
102 |
426 |
1.523e-05 |
0.0003561 |
200 |
REGULATION OF CELL MATRIX ADHESION |
31 |
90 |
1.553e-05 |
0.0003612 |
201 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
104 |
437 |
1.659e-05 |
0.0003839 |
202 |
MEMBRANE BIOGENESIS |
15 |
30 |
1.681e-05 |
0.0003871 |
203 |
EPITHELIAL CELL DIFFERENTIATION |
115 |
495 |
1.935e-05 |
0.0004435 |
204 |
INTRACELLULAR PROTEIN TRANSPORT |
169 |
781 |
2.117e-05 |
0.0004828 |
205 |
REGULATION OF KINASE ACTIVITY |
168 |
776 |
2.176e-05 |
0.0004901 |
206 |
SKELETAL SYSTEM DEVELOPMENT |
107 |
455 |
2.167e-05 |
0.0004901 |
207 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
20 |
48 |
2.18e-05 |
0.0004901 |
208 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
33 |
100 |
2.313e-05 |
0.0005173 |
209 |
CAMP METABOLIC PROCESS |
16 |
34 |
2.331e-05 |
0.000519 |
210 |
REGULATION OF CELL DEATH |
294 |
1472 |
2.462e-05 |
0.0005455 |
211 |
RESPONSE TO ESTROGEN |
59 |
218 |
2.499e-05 |
0.0005512 |
212 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
38 |
122 |
2.562e-05 |
0.0005623 |
213 |
PROTEIN DEPHOSPHORYLATION |
53 |
190 |
2.583e-05 |
0.0005643 |
214 |
HORMONE MEDIATED SIGNALING PATHWAY |
46 |
158 |
2.694e-05 |
0.0005858 |
215 |
GOLGI ORGANIZATION |
29 |
84 |
2.746e-05 |
0.0005915 |
216 |
POSITIVE REGULATION OF OSSIFICATION |
29 |
84 |
2.746e-05 |
0.0005915 |
217 |
REGULATION OF CATABOLIC PROCESS |
159 |
731 |
2.776e-05 |
0.0005952 |
218 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
68 |
262 |
2.792e-05 |
0.0005959 |
219 |
REGULATION OF MITOTIC CELL CYCLE |
109 |
468 |
2.82e-05 |
0.0005991 |
220 |
SYNAPSE ORGANIZATION |
43 |
145 |
2.988e-05 |
0.000632 |
221 |
FOREBRAIN DEVELOPMENT |
87 |
357 |
3.154e-05 |
0.000664 |
222 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
108 |
465 |
3.463e-05 |
0.0007259 |
223 |
PROTEIN AUTOPHOSPHORYLATION |
53 |
192 |
3.531e-05 |
0.0007367 |
224 |
REGULATION OF CELL PROLIFERATION |
297 |
1496 |
3.581e-05 |
0.0007439 |
225 |
RESPONSE TO PEPTIDE |
96 |
404 |
3.666e-05 |
0.0007548 |
226 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
16 |
35 |
3.654e-05 |
0.0007548 |
227 |
REGULATION OF MAPK CASCADE |
145 |
660 |
3.704e-05 |
0.0007592 |
228 |
REGULATION OF BMP SIGNALING PATHWAY |
27 |
77 |
3.75e-05 |
0.0007653 |
229 |
REGULATION OF PLASMA MEMBRANE ORGANIZATION |
26 |
73 |
3.814e-05 |
0.000775 |
230 |
MEMORY |
32 |
98 |
3.871e-05 |
0.000783 |
231 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
109 |
472 |
4.112e-05 |
0.0008283 |
232 |
SENSORY ORGAN DEVELOPMENT |
113 |
493 |
4.204e-05 |
0.0008431 |
233 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
89 |
370 |
4.315e-05 |
0.0008618 |
234 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
135 |
609 |
4.38e-05 |
0.000871 |
235 |
ERBB2 SIGNALING PATHWAY |
17 |
39 |
4.47e-05 |
0.0008851 |
236 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
36 |
116 |
4.501e-05 |
0.0008875 |
237 |
BIOLOGICAL ADHESION |
213 |
1032 |
4.578e-05 |
0.0008989 |
238 |
KIDNEY EPITHELIUM DEVELOPMENT |
38 |
125 |
4.66e-05 |
0.000911 |
239 |
WNT SIGNALING PATHWAY |
85 |
351 |
4.916e-05 |
0.000957 |
240 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
136 |
616 |
5.02e-05 |
0.0009733 |
241 |
PEPTIDYL SERINE MODIFICATION |
43 |
148 |
5.113e-05 |
0.0009871 |
242 |
REGULATION OF LIPID METABOLIC PROCESS |
71 |
282 |
5.453e-05 |
0.001048 |
243 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
77 |
312 |
5.588e-05 |
0.00107 |
244 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
42 |
144 |
5.632e-05 |
0.001074 |
245 |
REGULATION OF SYSTEM PROCESS |
115 |
507 |
5.78e-05 |
0.001098 |
246 |
MEMBRANE ORGANIZATION |
188 |
899 |
5.988e-05 |
0.001133 |
247 |
RESPONSE TO METAL ION |
81 |
333 |
6.214e-05 |
0.001171 |
248 |
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
21 |
55 |
6.498e-05 |
0.001219 |
249 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
9 |
14 |
6.622e-05 |
0.001238 |
250 |
REGULATION OF AXONOGENESIS |
47 |
168 |
6.651e-05 |
0.001238 |
251 |
PROTEIN LOCALIZATION TO ORGANELLE |
124 |
556 |
6.686e-05 |
0.001239 |
252 |
CELL PROJECTION ASSEMBLY |
67 |
264 |
6.72e-05 |
0.001241 |
253 |
EMBRYONIC AXIS SPECIFICATION |
15 |
33 |
6.937e-05 |
0.001276 |
254 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
300 |
1527 |
7.283e-05 |
0.001334 |
255 |
PROTEIN K48 LINKED DEUBIQUITINATION |
11 |
20 |
7.502e-05 |
0.001369 |
256 |
NEURON MIGRATION |
34 |
110 |
7.912e-05 |
0.001438 |
257 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
42 |
146 |
7.973e-05 |
0.001444 |
258 |
CYTOSKELETON ORGANIZATION |
176 |
838 |
8.063e-05 |
0.001454 |
259 |
CIRCULATORY SYSTEM PROCESS |
87 |
366 |
8.189e-05 |
0.001471 |
260 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY |
16 |
37 |
8.395e-05 |
0.001491 |
261 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
16 |
37 |
8.395e-05 |
0.001491 |
262 |
NEGATIVE REGULATION OF CELL CYCLE |
100 |
433 |
8.35e-05 |
0.001491 |
263 |
NEURON MATURATION |
14 |
30 |
8.48e-05 |
0.0015 |
264 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
123 |
554 |
8.756e-05 |
0.001539 |
265 |
DEPHOSPHORYLATION |
71 |
286 |
8.766e-05 |
0.001539 |
266 |
PROTEIN COMPLEX BIOGENESIS |
229 |
1132 |
8.932e-05 |
0.001557 |
267 |
PROTEIN COMPLEX ASSEMBLY |
229 |
1132 |
8.932e-05 |
0.001557 |
268 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
17 |
41 |
9.612e-05 |
0.001646 |
269 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
17 |
41 |
9.612e-05 |
0.001646 |
270 |
REGULATION OF HORMONE SECRETION |
66 |
262 |
9.619e-05 |
0.001646 |
271 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
17 |
41 |
9.612e-05 |
0.001646 |
272 |
CELL CYCLE CHECKPOINT |
52 |
194 |
9.615e-05 |
0.001646 |
273 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
70 |
282 |
9.821e-05 |
0.001668 |
274 |
PEPTIDYL AMINO ACID MODIFICATION |
176 |
841 |
9.815e-05 |
0.001668 |
275 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
53 |
199 |
9.926e-05 |
0.001678 |
276 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
31 |
98 |
9.955e-05 |
0.001678 |
277 |
POSITIVE REGULATION OF CELL PROLIFERATION |
171 |
814 |
0.0001001 |
0.001681 |
278 |
METANEPHROS DEVELOPMENT |
27 |
81 |
0.000102 |
0.001708 |
279 |
REGULATION OF NEUROTRANSMITTER LEVELS |
51 |
190 |
0.0001074 |
0.001785 |
280 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
56 |
214 |
0.0001074 |
0.001785 |
281 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
74 |
303 |
0.0001101 |
0.001823 |
282 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
19 |
49 |
0.0001124 |
0.001855 |
283 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
32 |
103 |
0.0001137 |
0.001869 |
284 |
IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY |
12 |
24 |
0.0001192 |
0.001952 |
285 |
REGULATION OF EXOCYTOSIS |
50 |
186 |
0.0001199 |
0.001957 |
286 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
69 |
279 |
0.0001235 |
0.00201 |
287 |
RESPONSE TO UV |
37 |
126 |
0.0001299 |
0.002106 |
288 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
17 |
42 |
0.0001374 |
0.00222 |
289 |
CHEMICAL HOMEOSTASIS |
181 |
874 |
0.0001402 |
0.002254 |
290 |
CELL DEATH |
204 |
1001 |
0.0001405 |
0.002254 |
291 |
SIGNAL RELEASE |
47 |
173 |
0.0001438 |
0.002284 |
292 |
REGULATION OF CELL SUBSTRATE ADHESION |
47 |
173 |
0.0001438 |
0.002284 |
293 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
228 |
1135 |
0.0001437 |
0.002284 |
294 |
RESPONSE TO RADIATION |
95 |
413 |
0.0001445 |
0.002287 |
295 |
RESPIRATORY SYSTEM DEVELOPMENT |
52 |
197 |
0.0001467 |
0.002314 |
296 |
PEPTIDYL THREONINE MODIFICATION |
18 |
46 |
0.0001476 |
0.00232 |
297 |
POSITIVE REGULATION OF ION TRANSPORT |
60 |
236 |
0.0001487 |
0.002324 |
298 |
EYE DEVELOPMENT |
78 |
326 |
0.0001489 |
0.002324 |
299 |
REGULATION OF OSSIFICATION |
48 |
178 |
0.0001494 |
0.002325 |
300 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
19 |
50 |
0.0001541 |
0.002391 |
301 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
22 |
62 |
0.0001566 |
0.002421 |
302 |
RESPONSE TO IRON ION |
15 |
35 |
0.0001576 |
0.002428 |
303 |
POSITIVE REGULATION OF KINASE ACTIVITY |
108 |
482 |
0.0001585 |
0.002434 |
304 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
40 |
141 |
0.0001618 |
0.002475 |
305 |
REGULATION OF POTASSIUM ION TRANSPORT |
27 |
83 |
0.0001622 |
0.002475 |
306 |
GLYCOPROTEIN METABOLIC PROCESS |
83 |
353 |
0.0001732 |
0.002634 |
307 |
REGULATION OF HORMONE LEVELS |
107 |
478 |
0.0001763 |
0.002672 |
308 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
16 |
39 |
0.0001782 |
0.002676 |
309 |
LONG TERM SYNAPTIC POTENTIATION |
16 |
39 |
0.0001782 |
0.002676 |
310 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
49 |
184 |
0.0001783 |
0.002676 |
311 |
REGULATION OF CELL CYCLE PROCESS |
122 |
558 |
0.0001833 |
0.002743 |
312 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
37 |
128 |
0.0001849 |
0.002749 |
313 |
MUSCLE CELL DEVELOPMENT |
37 |
128 |
0.0001849 |
0.002749 |
314 |
TELENCEPHALON DEVELOPMENT |
58 |
228 |
0.0001867 |
0.002767 |
315 |
RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
59 |
233 |
0.0001887 |
0.002778 |
316 |
CONNECTIVE TISSUE DEVELOPMENT |
51 |
194 |
0.0001883 |
0.002778 |
317 |
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
24 |
71 |
0.0001904 |
0.002781 |
318 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
43 |
156 |
0.0001907 |
0.002781 |
319 |
POSITIVE REGULATION OF GROWTH |
60 |
238 |
0.0001904 |
0.002781 |
320 |
PROTEIN POLYUBIQUITINATION |
61 |
243 |
0.0001918 |
0.002788 |
321 |
MEMBRANE ASSEMBLY |
12 |
25 |
0.0001957 |
0.002836 |
322 |
REGULATION OF CALCIUM ION TRANSPORT |
54 |
209 |
0.0002004 |
0.002896 |
323 |
FAT CELL DIFFERENTIATION |
32 |
106 |
0.000206 |
0.002967 |
324 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
34 |
115 |
0.0002069 |
0.002971 |
325 |
STEM CELL DIFFERENTIATION |
50 |
190 |
0.0002107 |
0.003016 |
326 |
ION HOMEOSTASIS |
125 |
576 |
0.000213 |
0.00304 |
327 |
EAR DEVELOPMENT |
51 |
195 |
0.0002157 |
0.003062 |
328 |
CELL CYCLE PROCESS |
217 |
1081 |
0.0002158 |
0.003062 |
329 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
218 |
1087 |
0.0002207 |
0.003121 |
330 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
31 |
102 |
0.0002248 |
0.00317 |
331 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
33 |
111 |
0.0002272 |
0.003193 |
332 |
PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
38 |
134 |
0.0002347 |
0.003279 |
333 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
28 |
89 |
0.0002343 |
0.003279 |
334 |
RESPONSE TO NUTRIENT |
50 |
191 |
0.0002415 |
0.003354 |
335 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
50 |
191 |
0.0002415 |
0.003354 |
336 |
MUSCLE TISSUE DEVELOPMENT |
67 |
275 |
0.0002437 |
0.003371 |
337 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
62 |
250 |
0.0002441 |
0.003371 |
338 |
HOMEOSTATIC PROCESS |
262 |
1337 |
0.0002487 |
0.003424 |
339 |
REGULATION OF ION HOMEOSTASIS |
52 |
201 |
0.0002514 |
0.003451 |
340 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
16 |
40 |
0.0002529 |
0.00346 |
341 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
23 |
68 |
0.0002543 |
0.00346 |
342 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
137 |
643 |
0.0002537 |
0.00346 |
343 |
REGULATION OF LONG TERM SYNAPTIC POTENTIATION |
10 |
19 |
0.0002605 |
0.003534 |
344 |
RESPONSE TO KETONE |
48 |
182 |
0.0002637 |
0.003567 |
345 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
35 |
121 |
0.0002684 |
0.003599 |
346 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
35 |
121 |
0.0002684 |
0.003599 |
347 |
GDP METABOLIC PROCESS |
8 |
13 |
0.0002679 |
0.003599 |
348 |
RESPONSE TO GLUCAGON |
18 |
48 |
0.0002769 |
0.003701 |
349 |
REGULATION OF PROTEIN SECRETION |
89 |
389 |
0.0002784 |
0.003701 |
350 |
OUTFLOW TRACT MORPHOGENESIS |
20 |
56 |
0.0002783 |
0.003701 |
351 |
CELL PROLIFERATION |
142 |
672 |
0.0002891 |
0.003833 |
352 |
NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
37 |
131 |
0.0003071 |
0.004052 |
353 |
REGULATION OF NEURON DEATH |
62 |
252 |
0.0003074 |
0.004052 |
354 |
REGULATION OF ION TRANSPORT |
127 |
592 |
0.0003135 |
0.004121 |
355 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
35 |
122 |
0.0003189 |
0.00418 |
356 |
GLIAL CELL DIFFERENTIATION |
38 |
136 |
0.0003252 |
0.00425 |
357 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
15 |
37 |
0.0003299 |
0.004288 |
358 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
15 |
37 |
0.0003299 |
0.004288 |
359 |
REGULATION OF BINDING |
68 |
283 |
0.0003356 |
0.004344 |
360 |
CARDIAC CONDUCTION |
26 |
82 |
0.0003361 |
0.004344 |
361 |
POSITIVE REGULATION OF BINDING |
36 |
127 |
0.0003407 |
0.004391 |
362 |
REGULATION OF VASCULATURE DEVELOPMENT |
58 |
233 |
0.0003428 |
0.004406 |
363 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
21 |
61 |
0.0003537 |
0.004497 |
364 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
21 |
61 |
0.0003537 |
0.004497 |
365 |
GLUTAMATE RECEPTOR SIGNALING PATHWAY |
16 |
41 |
0.0003533 |
0.004497 |
366 |
ANDROGEN RECEPTOR SIGNALING PATHWAY |
16 |
41 |
0.0003533 |
0.004497 |
367 |
RESPONSE TO ESTRADIOL |
40 |
146 |
0.0003586 |
0.004527 |
368 |
REGULATION OF GLUCOSE TRANSPORT |
30 |
100 |
0.0003609 |
0.004527 |
369 |
DNA INTEGRITY CHECKPOINT |
40 |
146 |
0.0003586 |
0.004527 |
370 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
32 |
109 |
0.0003601 |
0.004527 |
371 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
30 |
100 |
0.0003609 |
0.004527 |
372 |
SPROUTING ANGIOGENESIS |
17 |
45 |
0.000367 |
0.004591 |
373 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
19 |
53 |
0.0003711 |
0.004629 |
374 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
92 |
408 |
0.0003739 |
0.004629 |
375 |
REGULATION OF PEPTIDE SECRETION |
53 |
209 |
0.000374 |
0.004629 |
376 |
CARDIAC CELL DEVELOPMENT |
18 |
49 |
0.0003725 |
0.004629 |
377 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
13 |
30 |
0.0003775 |
0.004654 |
378 |
CELLULAR HOMEOSTASIS |
142 |
676 |
0.0003781 |
0.004654 |
379 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
24 |
74 |
0.0003855 |
0.004733 |
380 |
EXOCYTOSIS |
73 |
310 |
0.0003929 |
0.004811 |
381 |
CARDIOCYTE DIFFERENTIATION |
29 |
96 |
0.0003949 |
0.004823 |
382 |
REGULATION OF BLOOD CIRCULATION |
70 |
295 |
0.0004063 |
0.004949 |
383 |
RESPONSE TO ALCOHOL |
83 |
362 |
0.0004081 |
0.004958 |
384 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
23 |
70 |
0.0004099 |
0.004967 |
385 |
REGULATION OF RESPONSE TO STRESS |
283 |
1468 |
0.0004252 |
0.005139 |
386 |
RENAL WATER HOMEOSTASIS |
14 |
34 |
0.0004289 |
0.00517 |
387 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
22 |
66 |
0.0004332 |
0.005177 |
388 |
CELLULAR RESPONSE TO UV |
22 |
66 |
0.0004332 |
0.005177 |
389 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
22 |
66 |
0.0004332 |
0.005177 |
390 |
HEMOSTASIS |
73 |
311 |
0.0004339 |
0.005177 |
391 |
REGULATION OF CELLULAR COMPONENT SIZE |
78 |
337 |
0.0004444 |
0.005289 |
392 |
INOSITOL LIPID MEDIATED SIGNALING |
35 |
124 |
0.000446 |
0.005294 |
393 |
DENDRITE DEVELOPMENT |
25 |
79 |
0.0004481 |
0.005305 |
394 |
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT |
15 |
38 |
0.0004646 |
0.005473 |
395 |
ENDOPLASMIC RETICULUM ORGANIZATION |
15 |
38 |
0.0004646 |
0.005473 |
396 |
EMBRYONIC PATTERN SPECIFICATION |
20 |
58 |
0.000473 |
0.005558 |
397 |
TRANSITION METAL ION HOMEOSTASIS |
31 |
106 |
0.0004749 |
0.005566 |
398 |
ARTERY DEVELOPMENT |
24 |
75 |
0.0004815 |
0.005615 |
399 |
POSITIVE REGULATION OF AUTOPHAGY |
24 |
75 |
0.0004815 |
0.005615 |
400 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
40 |
148 |
0.0004843 |
0.005633 |
401 |
METAL ION TRANSPORT |
124 |
582 |
0.000487 |
0.005638 |
402 |
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS |
19 |
54 |
0.0004871 |
0.005638 |
403 |
REGULATION OF COENZYME METABOLIC PROCESS |
18 |
50 |
0.0004953 |
0.005676 |
404 |
REGULATION OF COFACTOR METABOLIC PROCESS |
18 |
50 |
0.0004953 |
0.005676 |
405 |
EMBRYONIC ORGAN DEVELOPMENT |
91 |
406 |
0.000494 |
0.005676 |
406 |
REGULATION OF DENDRITE DEVELOPMENT |
34 |
120 |
0.000495 |
0.005676 |
407 |
NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS |
26 |
84 |
0.0005106 |
0.005838 |
408 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
103 |
470 |
0.0005136 |
0.005857 |
409 |
CAMP CATABOLIC PROCESS |
8 |
14 |
0.0005367 |
0.006106 |
410 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
86 |
381 |
0.0005501 |
0.006228 |
411 |
CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT |
33 |
116 |
0.0005492 |
0.006228 |
412 |
REGULATION OF GROWTH |
133 |
633 |
0.0005642 |
0.006372 |
413 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
37 |
135 |
0.0005796 |
0.006514 |
414 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
41 |
154 |
0.0005789 |
0.006514 |
415 |
MITOTIC CELL CYCLE |
157 |
766 |
0.0006142 |
0.006887 |
416 |
HEART PROCESS |
26 |
85 |
0.0006245 |
0.006985 |
417 |
PROTEIN MONOUBIQUITINATION |
18 |
51 |
0.0006515 |
0.007269 |
418 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
16 |
43 |
0.0006597 |
0.007343 |
419 |
MACROMOLECULAR COMPLEX ASSEMBLY |
269 |
1398 |
0.0006613 |
0.007344 |
420 |
ORGANELLE ASSEMBLY |
107 |
495 |
0.0006771 |
0.007501 |
421 |
NERVE DEVELOPMENT |
22 |
68 |
0.0006887 |
0.007611 |
422 |
RESPONSE TO LIGHT STIMULUS |
66 |
280 |
0.0007053 |
0.007776 |
423 |
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT |
12 |
28 |
0.0007135 |
0.00783 |
424 |
MORPHOGENESIS OF A POLARIZED EPITHELIUM |
12 |
28 |
0.0007135 |
0.00783 |
425 |
CHROMATIN MODIFICATION |
115 |
539 |
0.0007246 |
0.007933 |
426 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
10 |
21 |
0.0007291 |
0.007964 |
427 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
30 |
104 |
0.0007466 |
0.008135 |
428 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
79 |
348 |
0.0007565 |
0.008224 |
429 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
148 |
720 |
0.0007649 |
0.008296 |
430 |
CHONDROCYTE DIFFERENTIATION |
20 |
60 |
0.0007764 |
0.008401 |
431 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
13 |
32 |
0.0007979 |
0.008574 |
432 |
POSITIVE REGULATION OF BMP SIGNALING PATHWAY |
13 |
32 |
0.0007979 |
0.008574 |
433 |
ADIPOSE TISSUE DEVELOPMENT |
13 |
32 |
0.0007979 |
0.008574 |
434 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
84 |
375 |
0.0008099 |
0.008683 |
435 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
19 |
56 |
0.0008153 |
0.008721 |
436 |
REGULATION OF PEPTIDE TRANSPORT |
61 |
256 |
0.0008239 |
0.008793 |
437 |
ENSHEATHMENT OF NEURONS |
27 |
91 |
0.0008377 |
0.008899 |
438 |
AXON ENSHEATHMENT |
27 |
91 |
0.0008377 |
0.008899 |
439 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
32 |
114 |
0.0008491 |
0.009 |
440 |
ACTIN FILAMENT BASED PROCESS |
98 |
450 |
0.0008606 |
0.009081 |
441 |
SYNAPSE ASSEMBLY |
22 |
69 |
0.0008593 |
0.009081 |
442 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
9 |
18 |
0.000868 |
0.009117 |
443 |
UTERUS DEVELOPMENT |
9 |
18 |
0.000868 |
0.009117 |
444 |
REGULATION OF LIPID KINASE ACTIVITY |
17 |
48 |
0.000872 |
0.009138 |
445 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
36 |
133 |
0.0008754 |
0.009154 |
446 |
FORELIMB MORPHOGENESIS |
15 |
40 |
0.000878 |
0.00916 |
447 |
REGULATION OF CELL DIVISION |
64 |
272 |
0.0008832 |
0.009193 |
448 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
37 |
138 |
0.000907 |
0.009399 |
449 |
RHYTHMIC PROCESS |
69 |
298 |
0.0009065 |
0.009399 |
450 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
206 |
1047 |
0.0009117 |
0.009427 |
451 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
204 |
1036 |
0.0009246 |
0.009477 |
452 |
REGULATION OF TRANSFERASE ACTIVITY |
188 |
946 |
0.0009259 |
0.009477 |
453 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
44 |
172 |
0.0009247 |
0.009477 |
454 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
204 |
1036 |
0.0009246 |
0.009477 |
455 |
REGULATION OF MAP KINASE ACTIVITY |
73 |
319 |
0.0009288 |
0.009477 |
456 |
GOLGI VESICLE TRANSPORT |
73 |
319 |
0.0009288 |
0.009477 |
457 |
RAS PROTEIN SIGNAL TRANSDUCTION |
38 |
143 |
0.0009356 |
0.009526 |
458 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
49 |
197 |
0.0009624 |
0.009777 |
459 |
MEMBRANE DEPOLARIZATION |
20 |
61 |
0.0009826 |
0.009933 |
460 |
LONG TERM SYNAPTIC DEPRESSION |
8 |
15 |
0.000988 |
0.009933 |
461 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
20 |
61 |
0.0009826 |
0.009933 |
462 |
PALLIUM DEVELOPMENT |
40 |
153 |
0.0009843 |
0.009933 |
463 |
DIVALENT INORGANIC CATION TRANSPORT |
63 |
268 |
0.0009884 |
0.009933 |